Breaking News Instant updates and real-time market news.

GEMP

Gemphire Therapeutics

$0.94

-0.26 (-21.67%)

08:28
06/27/19
06/27
08:28
06/27/19
08:28

Gemphire Therapeutics upgraded to Buy from Hold at Laidlaw

Laidlaw analyst Francois Brisebois upgraded Gemphire Therapeutics to Buy from Hold after the company recently announced topline results based on their preliminary review of the limited dataset from their investigator-led Phase 2a study of adult patients with FPLD, a rare genetic disorder that remains a very difficult patient population with no other alternative. He was encouraged that gemcabene showed reduction in TG in some patients at 12 weeks and "particularly impressed" with gemcabene's safety profile, Brisebois tells investors. The analyst, who noted that Gemphire won't start any of its Phase 3 studies before resolution of their clinical hold, said he believes the believes the selloff in the stock has been overdone since the FDA requested data from a sub-chronic toxicology study for additional information to remove their partial clinical hold. He keeps a $2 price target on the stock.

GEMP Gemphire Therapeutics
$0.94

-0.26 (-21.67%)

08/13/18
JEFF
08/13/18
DOWNGRADE
Target $2
JEFF
Hold
Gemphire Therapeutics downgraded to Hold from Buy at Jefferies
Jefferies analyst Matthew Andrews downgraded Gemphire Therapeutics to Hold and lowered his price target for the shares to $2 from $12. With the termination of the company's Phase 2a clinical trial of gemcabene in pediatric patients with non-alcoholic fatty liver disease, and the timing of data unclear from the ongoing familial partial lipodystrophy study, the analyst prefers to step to the sidelines. He estimates Gemphire has $1.30 of cash per share.
08/10/18
08/10/18
DOWNGRADE
Target $2

Neutral
Gemphire Therapeutics downgraded to Neutral with $2 target at Roth Capital
As previously reported, Roth Capital analyst Yasmeen Rahimi downgraded Gemphire Therapeutics to Neutral from Buy after the company announced the termination of its Phase 2a pediatric NAFLD trial due to unforeseen ALT and liver fat increases in three patients. This news follows last week's announcement that the FDA has requested additional toxicology studies on gemcabene before progression into the Phase 3 development and Rahimi now sees a lack of major catalysts for Gemphire in the next year. Rahimi cut the firm's price target on Gemphire to $2 from $40.
08/10/18
ROTH
08/10/18
DOWNGRADE
ROTH
Neutral
Gemphire Therapeutics downgraded to Neutral from Buy at Roth Capital
08/07/18
RAJA
08/07/18
DOWNGRADE
RAJA
Market Perform
Gemphire Therapeutics downgraded to Market Perform from Outperform at Raymond James

TODAY'S FREE FLY STORIES

SSRM

SSR Mining

$14.72

0.665 (4.73%)

12:25
07/17/19
07/17
12:25
07/17/19
12:25
Options
SSR Mining call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
07/17/19
07/17
12:25
07/17/19
12:25
General news
Treasury Action: the downdraft in European rates has helped pulling Treasury yields lower »

Treasury Action: the…

CAPR

Capricor Therapeutics

$6.39

0.48 (8.12%)

12:25
07/17/19
07/17
12:25
07/17/19
12:25
Conference/Events
Capricor Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

IBM

IBM

$142.94

-0.6 (-0.42%)

12:24
07/17/19
07/17
12:24
07/17/19
12:24
Earnings
Fly Intel: What to watch in IBM's earnings report »

IBM (IBM) is scheduled to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

AMZN

Amazon.com

$1,999.39

-10.61 (-0.53%)

, QCOM

Qualcomm

$76.74

1.08 (1.43%)

12:23
07/17/19
07/17
12:23
07/17/19
12:23
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have dropped in…

AMZN

Amazon.com

$1,999.39

-10.61 (-0.53%)

QCOM

Qualcomm

$76.74

1.08 (1.43%)

MSFT

Microsoft

$137.11

0.03 (0.02%)

T

AT&T

$33.47

-0.1 (-0.30%)

BAC

Bank of America

$29.47

0.475 (1.64%)

CSX

CSX

$71.11

-8.46 (-10.63%)

ABT

Abbott

$86.33

3.22 (3.87%)

SGEN

Seattle Genetics

$73.43

10.31 (16.33%)

INO

Inovio

$2.65

-0.35 (-11.67%)

NUS

Nu Skin

$37.95

-7.55 (-16.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 18

    Jul

  • 24

    Jul

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 06

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

  • 26

    Aug

  • 06

    Sep

  • 09

    Sep

  • 13

    Nov

KSU

Kansas City Southern

$118.05

-4.78 (-3.89%)

12:18
07/17/19
07/17
12:18
07/17/19
12:18
Downgrade
Kansas City Southern rating change  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 13

    Nov

NSC

Norfolk Southern

$194.90

-11.63 (-5.63%)

12:18
07/17/19
07/17
12:18
07/17/19
12:18
Downgrade
Norfolk Southern rating change  »

Norfolk Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 26

    Aug

CSX

CSX

$71.21

-8.36 (-10.51%)

12:18
07/17/19
07/17
12:18
07/17/19
12:18
Downgrade
CSX rating change  »

CSX downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 13

    Nov

UNP

Union Pacific

$166.50

-8.6 (-4.91%)

12:17
07/17/19
07/17
12:17
07/17/19
12:17
Downgrade
Union Pacific rating change at C.K. Cooper »

Union Pacific downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
07/17/19
07/17
12:17
07/17/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
07/17/19
07/17
12:16
07/17/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTAP

NetApp

$59.31

0.36 (0.61%)

12:15
07/17/19
07/17
12:15
07/17/19
12:15
Options
NetApp put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
07/17/19
07/17
12:15
07/17/19
12:15
General news
Breaking General news story  »

Kansas City Federal…

CBB

Cincinnati Bell

$4.28

-0.44 (-9.32%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
Cincinnati Bell falls -9.5% »

Cincinnati Bell is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$21.02

-2.08 (-9.00%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
Direxion Daily Junior Gold Miners Index Bear 3x Shares falls -9.0% »

Direxion Daily Junior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUS

Nu Skin

$38.13

-7.37 (-16.20%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
Nu Skin falls -16.0% »

Nu Skin is down -16.0%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

AG

First Majestic

$9.10

0.53 (6.18%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
First Majestic rises 6.2% »

First Majestic is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$70.17

5.71 (8.86%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
Direxion Daily Jr Gld Mnrs Bull 3X Shrs rises 8.7% »

Direxion Daily Jr Gld…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSM

Fortuna Silver Mines

$3.55

0.37 (11.65%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
Fortuna Silver Mines rises 11.6% »

Fortuna Silver Mines is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
07/17/19
07/17
11:55
07/17/19
11:55
General news
Oil Action: WTI crude »

Oil Action: WTI crude…

11:55
07/17/19
07/17
11:55
07/17/19
11:55
Conference/Events
Federal Reserve Bank of Kansas City to speak on economic outlook »

Kansas City Federal…

AVXL

Anavex

$3.03

(0.00%)

11:52
07/17/19
07/17
11:52
07/17/19
11:52
Hot Stocks
Anavex presents new clinical data identifying gut microbiota biomarkers »

Anavex Life Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$11.90

-0.01 (-0.08%)

11:50
07/17/19
07/17
11:50
07/17/19
11:50
Options
Call block in Caesar's noted as account swap from July 8th opener »

Call block in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$17.95

-0.48 (-2.60%)

11:45
07/17/19
07/17
11:45
07/17/19
11:45
Options
Mylan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

NTDOY

Nintendo

$0.00

(0.00%)

11:43
07/17/19
07/17
11:43
07/17/19
11:43
Periodicals
Nintendo to launch new Switch model with improved battery life, Kotaku says »

Nintendo plans to release…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.